P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network

C.M. Sloan, L.J. Sherrard, G.G. Einarsson, L.J. Dupont, S. van Koningsbruggen-Rietschel, N.J. Simmonds, D.G. Downey

Research output: Contribution to journalMeeting abstractpeer-review

Fingerprint

Dive into the research topics of 'P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science